Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin vs Standard Management in Hypertriglyceridemic Acute Pancreatitis
NCT05487833Phase 4Unknown
- Sponsor
- University Medical Centre Ljubljana
- Start
- Nov 2022
- Primary completion
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of human insulin in hypertriglyceridemia, acute pancreatitis (AP), sponsored by University Medical Centre Ljubljana. Status: unknown.
02
Drugs
human insulin
03
Conditions
hypertriglyceridemiaacute pancreatitis (AP)
Beyond the preview
Go deeper on NCT05487833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05487833.